Global Enzalutamide Soft Capsules Market Growth 2026-2032
The global Enzalutamide Soft Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Enzalutamide soft capsules are an oral medication used in the treatment of metastatic castration-resistant prostate cancer. Each soft capsule contains the active ingredient enzalutamide, a potent androgen receptor inhibitor that works by inhibiting the action of androgens (such as testosterone) on prostate cancer cells.
United States market for Enzalutamide Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Enzalutamide Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Enzalutamide Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Enzalutamide Soft Capsules players cover Astellas Pharma, Pfizer, Intas Pharmaceuticals, Aprazer Healthcare Pharma, Arechar Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Enzalutamide Soft Capsules Industry Forecast? looks at past sales and reviews total world Enzalutamide Soft Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Enzalutamide Soft Capsules sales for 2026 through 2032. With Enzalutamide Soft Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide Soft Capsules industry.
This Insight Report provides a comprehensive analysis of the global Enzalutamide Soft Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide Soft Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Enzalutamide Soft Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide Soft Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide Soft Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide Soft Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Enzalutamide Soft Capsules market?
What factors are driving Enzalutamide Soft Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide Soft Capsules market opportunities vary by end market size?
How does Enzalutamide Soft Capsules break out by Type, by Application?
Enzalutamide soft capsules are an oral medication used in the treatment of metastatic castration-resistant prostate cancer. Each soft capsule contains the active ingredient enzalutamide, a potent androgen receptor inhibitor that works by inhibiting the action of androgens (such as testosterone) on prostate cancer cells.
United States market for Enzalutamide Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Enzalutamide Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Enzalutamide Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Enzalutamide Soft Capsules players cover Astellas Pharma, Pfizer, Intas Pharmaceuticals, Aprazer Healthcare Pharma, Arechar Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Enzalutamide Soft Capsules Industry Forecast? looks at past sales and reviews total world Enzalutamide Soft Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Enzalutamide Soft Capsules sales for 2026 through 2032. With Enzalutamide Soft Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide Soft Capsules industry.
This Insight Report provides a comprehensive analysis of the global Enzalutamide Soft Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide Soft Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Enzalutamide Soft Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide Soft Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide Soft Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide Soft Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drug
- Generic Drug
- Hospital and Clinic
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas Pharma
- Pfizer
- Intas Pharmaceuticals
- Aprazer Healthcare Pharma
- Arechar Healthcare
- Glenmark Pharma
- BDR Pharma
- Qilu Pharmaceutical
- Kelun Pharmaceutical
- Yichang Humanwell Pharmaceutical
- Jiangsu Hansoh Pharmaceutical
- PuraCap Pharmaceuticals
- Shenyang Hongqi Pharmaceutical
What is the 10-year outlook for the global Enzalutamide Soft Capsules market?
What factors are driving Enzalutamide Soft Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide Soft Capsules market opportunities vary by end market size?
How does Enzalutamide Soft Capsules break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enzalutamide Soft Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Enzalutamide Soft Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Enzalutamide Soft Capsules by Country/Region, 2021, 2025 & 2032
2.2 Enzalutamide Soft Capsules Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Enzalutamide Soft Capsules Sales by Type
2.2.3.1 Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Enzalutamide Soft Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Enzalutamide Soft Capsules Sale Price by Type (2021-2026)
2.3 Enzalutamide Soft Capsules Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Enzalutamide Soft Capsules Sales by Application
2.3.4.1 Global Enzalutamide Soft Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Enzalutamide Soft Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Enzalutamide Soft Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Enzalutamide Soft Capsules Breakdown Data by Company
3.1.1 Global Enzalutamide Soft Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Enzalutamide Soft Capsules Sales Market Share by Company (2021-2026)
3.2 Global Enzalutamide Soft Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Enzalutamide Soft Capsules Revenue by Company (2021-2026)
3.2.2 Global Enzalutamide Soft Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Enzalutamide Soft Capsules Sale Price by Company
3.4 Key Manufacturers Enzalutamide Soft Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enzalutamide Soft Capsules Product Location Distribution
3.4.2 Players Enzalutamide Soft Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE SOFT CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Enzalutamide Soft Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Enzalutamide Soft Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Enzalutamide Soft Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Enzalutamide Soft Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Enzalutamide Soft Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Enzalutamide Soft Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Enzalutamide Soft Capsules Sales Growth
4.4 APAC Enzalutamide Soft Capsules Sales Growth
4.5 Europe Enzalutamide Soft Capsules Sales Growth
4.6 Middle East & Africa Enzalutamide Soft Capsules Sales Growth
5 AMERICAS
5.1 Americas Enzalutamide Soft Capsules Sales by Country
5.1.1 Americas Enzalutamide Soft Capsules Sales by Country (2021-2026)
5.1.2 Americas Enzalutamide Soft Capsules Revenue by Country (2021-2026)
5.2 Americas Enzalutamide Soft Capsules Sales by Type (2021-2026)
5.3 Americas Enzalutamide Soft Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enzalutamide Soft Capsules Sales by Region
6.1.1 APAC Enzalutamide Soft Capsules Sales by Region (2021-2026)
6.1.2 APAC Enzalutamide Soft Capsules Revenue by Region (2021-2026)
6.2 APAC Enzalutamide Soft Capsules Sales by Type (2021-2026)
6.3 APAC Enzalutamide Soft Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enzalutamide Soft Capsules by Country
7.1.1 Europe Enzalutamide Soft Capsules Sales by Country (2021-2026)
7.1.2 Europe Enzalutamide Soft Capsules Revenue by Country (2021-2026)
7.2 Europe Enzalutamide Soft Capsules Sales by Type (2021-2026)
7.3 Europe Enzalutamide Soft Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enzalutamide Soft Capsules by Country
8.1.1 Middle East & Africa Enzalutamide Soft Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Enzalutamide Soft Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Enzalutamide Soft Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Enzalutamide Soft Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide Soft Capsules
10.3 Manufacturing Process Analysis of Enzalutamide Soft Capsules
10.4 Industry Chain Structure of Enzalutamide Soft Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enzalutamide Soft Capsules Distributors
11.3 Enzalutamide Soft Capsules Customer
12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE SOFT CAPSULES BY GEOGRAPHIC REGION
12.1 Global Enzalutamide Soft Capsules Market Size Forecast by Region
12.1.1 Global Enzalutamide Soft Capsules Forecast by Region (2027-2032)
12.1.2 Global Enzalutamide Soft Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Enzalutamide Soft Capsules Forecast by Type (2027-2032)
12.7 Global Enzalutamide Soft Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Information
13.1.2 Astellas Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.1.3 Astellas Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Pharma Main Business Overview
13.1.5 Astellas Pharma Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Enzalutamide Soft Capsules Product Portfolios and Specifications
13.2.3 Pfizer Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
13.3.3 Intas Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Aprazer Healthcare Pharma
13.4.1 Aprazer Healthcare Pharma Company Information
13.4.2 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.4.3 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Aprazer Healthcare Pharma Main Business Overview
13.4.5 Aprazer Healthcare Pharma Latest Developments
13.5 Arechar Healthcare
13.5.1 Arechar Healthcare Company Information
13.5.2 Arechar Healthcare Enzalutamide Soft Capsules Product Portfolios and Specifications
13.5.3 Arechar Healthcare Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Arechar Healthcare Main Business Overview
13.5.5 Arechar Healthcare Latest Developments
13.6 Glenmark Pharma
13.6.1 Glenmark Pharma Company Information
13.6.2 Glenmark Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.6.3 Glenmark Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Glenmark Pharma Main Business Overview
13.6.5 Glenmark Pharma Latest Developments
13.7 BDR Pharma
13.7.1 BDR Pharma Company Information
13.7.2 BDR Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.7.3 BDR Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BDR Pharma Main Business Overview
13.7.5 BDR Pharma Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Kelun Pharmaceutical
13.9.1 Kelun Pharmaceutical Company Information
13.9.2 Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.9.3 Kelun Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Kelun Pharmaceutical Main Business Overview
13.9.5 Kelun Pharmaceutical Latest Developments
13.10 Yichang Humanwell Pharmaceutical
13.10.1 Yichang Humanwell Pharmaceutical Company Information
13.10.2 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.10.3 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yichang Humanwell Pharmaceutical Main Business Overview
13.10.5 Yichang Humanwell Pharmaceutical Latest Developments
13.11 Jiangsu Hansoh Pharmaceutical
13.11.1 Jiangsu Hansoh Pharmaceutical Company Information
13.11.2 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.11.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.11.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.12 PuraCap Pharmaceuticals
13.12.1 PuraCap Pharmaceuticals Company Information
13.12.2 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
13.12.3 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 PuraCap Pharmaceuticals Main Business Overview
13.12.5 PuraCap Pharmaceuticals Latest Developments
13.13 Shenyang Hongqi Pharmaceutical
13.13.1 Shenyang Hongqi Pharmaceutical Company Information
13.13.2 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.13.3 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shenyang Hongqi Pharmaceutical Main Business Overview
13.13.5 Shenyang Hongqi Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enzalutamide Soft Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Enzalutamide Soft Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Enzalutamide Soft Capsules by Country/Region, 2021, 2025 & 2032
2.2 Enzalutamide Soft Capsules Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Enzalutamide Soft Capsules Sales by Type
2.2.3.1 Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Enzalutamide Soft Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Enzalutamide Soft Capsules Sale Price by Type (2021-2026)
2.3 Enzalutamide Soft Capsules Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Enzalutamide Soft Capsules Sales by Application
2.3.4.1 Global Enzalutamide Soft Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Enzalutamide Soft Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Enzalutamide Soft Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Enzalutamide Soft Capsules Breakdown Data by Company
3.1.1 Global Enzalutamide Soft Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Enzalutamide Soft Capsules Sales Market Share by Company (2021-2026)
3.2 Global Enzalutamide Soft Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Enzalutamide Soft Capsules Revenue by Company (2021-2026)
3.2.2 Global Enzalutamide Soft Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Enzalutamide Soft Capsules Sale Price by Company
3.4 Key Manufacturers Enzalutamide Soft Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enzalutamide Soft Capsules Product Location Distribution
3.4.2 Players Enzalutamide Soft Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE SOFT CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Enzalutamide Soft Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Enzalutamide Soft Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Enzalutamide Soft Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Enzalutamide Soft Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Enzalutamide Soft Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Enzalutamide Soft Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Enzalutamide Soft Capsules Sales Growth
4.4 APAC Enzalutamide Soft Capsules Sales Growth
4.5 Europe Enzalutamide Soft Capsules Sales Growth
4.6 Middle East & Africa Enzalutamide Soft Capsules Sales Growth
5 AMERICAS
5.1 Americas Enzalutamide Soft Capsules Sales by Country
5.1.1 Americas Enzalutamide Soft Capsules Sales by Country (2021-2026)
5.1.2 Americas Enzalutamide Soft Capsules Revenue by Country (2021-2026)
5.2 Americas Enzalutamide Soft Capsules Sales by Type (2021-2026)
5.3 Americas Enzalutamide Soft Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enzalutamide Soft Capsules Sales by Region
6.1.1 APAC Enzalutamide Soft Capsules Sales by Region (2021-2026)
6.1.2 APAC Enzalutamide Soft Capsules Revenue by Region (2021-2026)
6.2 APAC Enzalutamide Soft Capsules Sales by Type (2021-2026)
6.3 APAC Enzalutamide Soft Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enzalutamide Soft Capsules by Country
7.1.1 Europe Enzalutamide Soft Capsules Sales by Country (2021-2026)
7.1.2 Europe Enzalutamide Soft Capsules Revenue by Country (2021-2026)
7.2 Europe Enzalutamide Soft Capsules Sales by Type (2021-2026)
7.3 Europe Enzalutamide Soft Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enzalutamide Soft Capsules by Country
8.1.1 Middle East & Africa Enzalutamide Soft Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Enzalutamide Soft Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Enzalutamide Soft Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Enzalutamide Soft Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide Soft Capsules
10.3 Manufacturing Process Analysis of Enzalutamide Soft Capsules
10.4 Industry Chain Structure of Enzalutamide Soft Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enzalutamide Soft Capsules Distributors
11.3 Enzalutamide Soft Capsules Customer
12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE SOFT CAPSULES BY GEOGRAPHIC REGION
12.1 Global Enzalutamide Soft Capsules Market Size Forecast by Region
12.1.1 Global Enzalutamide Soft Capsules Forecast by Region (2027-2032)
12.1.2 Global Enzalutamide Soft Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Enzalutamide Soft Capsules Forecast by Type (2027-2032)
12.7 Global Enzalutamide Soft Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Information
13.1.2 Astellas Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.1.3 Astellas Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Pharma Main Business Overview
13.1.5 Astellas Pharma Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Enzalutamide Soft Capsules Product Portfolios and Specifications
13.2.3 Pfizer Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
13.3.3 Intas Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Aprazer Healthcare Pharma
13.4.1 Aprazer Healthcare Pharma Company Information
13.4.2 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.4.3 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Aprazer Healthcare Pharma Main Business Overview
13.4.5 Aprazer Healthcare Pharma Latest Developments
13.5 Arechar Healthcare
13.5.1 Arechar Healthcare Company Information
13.5.2 Arechar Healthcare Enzalutamide Soft Capsules Product Portfolios and Specifications
13.5.3 Arechar Healthcare Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Arechar Healthcare Main Business Overview
13.5.5 Arechar Healthcare Latest Developments
13.6 Glenmark Pharma
13.6.1 Glenmark Pharma Company Information
13.6.2 Glenmark Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.6.3 Glenmark Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Glenmark Pharma Main Business Overview
13.6.5 Glenmark Pharma Latest Developments
13.7 BDR Pharma
13.7.1 BDR Pharma Company Information
13.7.2 BDR Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
13.7.3 BDR Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BDR Pharma Main Business Overview
13.7.5 BDR Pharma Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Kelun Pharmaceutical
13.9.1 Kelun Pharmaceutical Company Information
13.9.2 Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.9.3 Kelun Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Kelun Pharmaceutical Main Business Overview
13.9.5 Kelun Pharmaceutical Latest Developments
13.10 Yichang Humanwell Pharmaceutical
13.10.1 Yichang Humanwell Pharmaceutical Company Information
13.10.2 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.10.3 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yichang Humanwell Pharmaceutical Main Business Overview
13.10.5 Yichang Humanwell Pharmaceutical Latest Developments
13.11 Jiangsu Hansoh Pharmaceutical
13.11.1 Jiangsu Hansoh Pharmaceutical Company Information
13.11.2 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.11.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.11.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.12 PuraCap Pharmaceuticals
13.12.1 PuraCap Pharmaceuticals Company Information
13.12.2 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
13.12.3 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 PuraCap Pharmaceuticals Main Business Overview
13.12.5 PuraCap Pharmaceuticals Latest Developments
13.13 Shenyang Hongqi Pharmaceutical
13.13.1 Shenyang Hongqi Pharmaceutical Company Information
13.13.2 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
13.13.3 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shenyang Hongqi Pharmaceutical Main Business Overview
13.13.5 Shenyang Hongqi Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Enzalutamide Soft Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Enzalutamide Soft Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Enzalutamide Soft Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Enzalutamide Soft Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Enzalutamide Soft Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Enzalutamide Soft Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Enzalutamide Soft Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Enzalutamide Soft Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Enzalutamide Soft Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Enzalutamide Soft Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Enzalutamide Soft Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Enzalutamide Soft Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Enzalutamide Soft Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Enzalutamide Soft Capsules Producing Area Distribution and Sales Area
Table 21. Players Enzalutamide Soft Capsules Products Offered
Table 22. Enzalutamide Soft Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Enzalutamide Soft Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Enzalutamide Soft Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Enzalutamide Soft Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Enzalutamide Soft Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Enzalutamide Soft Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Enzalutamide Soft Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Enzalutamide Soft Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Enzalutamide Soft Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Enzalutamide Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Enzalutamide Soft Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Enzalutamide Soft Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Enzalutamide Soft Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Enzalutamide Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Enzalutamide Soft Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Enzalutamide Soft Capsules
Table 52. Key Market Challenges & Risks of Enzalutamide Soft Capsules
Table 53. Key Industry Trends of Enzalutamide Soft Capsules
Table 54. Enzalutamide Soft Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Enzalutamide Soft Capsules Distributors List
Table 57. Enzalutamide Soft Capsules Customer List
Table 58. Global Enzalutamide Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Enzalutamide Soft Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Enzalutamide Soft Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Enzalutamide Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Enzalutamide Soft Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Enzalutamide Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Enzalutamide Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Enzalutamide Soft Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Enzalutamide Soft Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Enzalutamide Soft Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Enzalutamide Soft Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 74. Astellas Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Pfizer Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 79. Pfizer Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Intas Pharmaceuticals Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 84. Intas Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Intas Pharmaceuticals Main Business
Table 86. Intas Pharmaceuticals Latest Developments
Table 87. Aprazer Healthcare Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 89. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Aprazer Healthcare Pharma Main Business
Table 91. Aprazer Healthcare Pharma Latest Developments
Table 92. Arechar Healthcare Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. Arechar Healthcare Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 94. Arechar Healthcare Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Arechar Healthcare Main Business
Table 96. Arechar Healthcare Latest Developments
Table 97. Glenmark Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Glenmark Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 99. Glenmark Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Glenmark Pharma Main Business
Table 101. Glenmark Pharma Latest Developments
Table 102. BDR Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. BDR Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 104. BDR Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. BDR Pharma Main Business
Table 106. BDR Pharma Latest Developments
Table 107. Qilu Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 109. Qilu Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Qilu Pharmaceutical Main Business
Table 111. Qilu Pharmaceutical Latest Developments
Table 112. Kelun Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 113. Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 114. Kelun Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Kelun Pharmaceutical Main Business
Table 116. Kelun Pharmaceutical Latest Developments
Table 117. Yichang Humanwell Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 118. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 119. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Yichang Humanwell Pharmaceutical Main Business
Table 121. Yichang Humanwell Pharmaceutical Latest Developments
Table 122. Jiangsu Hansoh Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 124. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jiangsu Hansoh Pharmaceutical Main Business
Table 126. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 127. PuraCap Pharmaceuticals Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 128. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 129. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. PuraCap Pharmaceuticals Main Business
Table 131. PuraCap Pharmaceuticals Latest Developments
Table 132. Shenyang Hongqi Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 133. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 134. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shenyang Hongqi Pharmaceutical Main Business
Table 136. Shenyang Hongqi Pharmaceutical Latest Developments
Table 1. Enzalutamide Soft Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Enzalutamide Soft Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Enzalutamide Soft Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Enzalutamide Soft Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Enzalutamide Soft Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Enzalutamide Soft Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Enzalutamide Soft Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Enzalutamide Soft Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Enzalutamide Soft Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Enzalutamide Soft Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Enzalutamide Soft Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Enzalutamide Soft Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Enzalutamide Soft Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Enzalutamide Soft Capsules Producing Area Distribution and Sales Area
Table 21. Players Enzalutamide Soft Capsules Products Offered
Table 22. Enzalutamide Soft Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Enzalutamide Soft Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Enzalutamide Soft Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Enzalutamide Soft Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Enzalutamide Soft Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Enzalutamide Soft Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Enzalutamide Soft Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Enzalutamide Soft Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Enzalutamide Soft Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Enzalutamide Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Enzalutamide Soft Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Enzalutamide Soft Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Enzalutamide Soft Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Enzalutamide Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Enzalutamide Soft Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Enzalutamide Soft Capsules
Table 52. Key Market Challenges & Risks of Enzalutamide Soft Capsules
Table 53. Key Industry Trends of Enzalutamide Soft Capsules
Table 54. Enzalutamide Soft Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Enzalutamide Soft Capsules Distributors List
Table 57. Enzalutamide Soft Capsules Customer List
Table 58. Global Enzalutamide Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Enzalutamide Soft Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Enzalutamide Soft Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Enzalutamide Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Enzalutamide Soft Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Enzalutamide Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Enzalutamide Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Enzalutamide Soft Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Enzalutamide Soft Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Enzalutamide Soft Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Enzalutamide Soft Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 74. Astellas Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Pfizer Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 79. Pfizer Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Intas Pharmaceuticals Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 84. Intas Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Intas Pharmaceuticals Main Business
Table 86. Intas Pharmaceuticals Latest Developments
Table 87. Aprazer Healthcare Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 89. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Aprazer Healthcare Pharma Main Business
Table 91. Aprazer Healthcare Pharma Latest Developments
Table 92. Arechar Healthcare Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. Arechar Healthcare Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 94. Arechar Healthcare Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Arechar Healthcare Main Business
Table 96. Arechar Healthcare Latest Developments
Table 97. Glenmark Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Glenmark Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 99. Glenmark Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Glenmark Pharma Main Business
Table 101. Glenmark Pharma Latest Developments
Table 102. BDR Pharma Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. BDR Pharma Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 104. BDR Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. BDR Pharma Main Business
Table 106. BDR Pharma Latest Developments
Table 107. Qilu Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 109. Qilu Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Qilu Pharmaceutical Main Business
Table 111. Qilu Pharmaceutical Latest Developments
Table 112. Kelun Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 113. Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 114. Kelun Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Kelun Pharmaceutical Main Business
Table 116. Kelun Pharmaceutical Latest Developments
Table 117. Yichang Humanwell Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 118. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 119. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Yichang Humanwell Pharmaceutical Main Business
Table 121. Yichang Humanwell Pharmaceutical Latest Developments
Table 122. Jiangsu Hansoh Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 124. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jiangsu Hansoh Pharmaceutical Main Business
Table 126. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 127. PuraCap Pharmaceuticals Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 128. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 129. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. PuraCap Pharmaceuticals Main Business
Table 131. PuraCap Pharmaceuticals Latest Developments
Table 132. Shenyang Hongqi Pharmaceutical Basic Information, Enzalutamide Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 133. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolios and Specifications
Table 134. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shenyang Hongqi Pharmaceutical Main Business
Table 136. Shenyang Hongqi Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Enzalutamide Soft Capsules
Figure 2. Enzalutamide Soft Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzalutamide Soft Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Enzalutamide Soft Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Enzalutamide Soft Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Enzalutamide Soft Capsules Sales Market Share by Country/Region (2025)
Figure 10. Enzalutamide Soft Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Enzalutamide Soft Capsules Sales Market Share by Type in 2026
Figure 14. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Enzalutamide Soft Capsules Consumed in Hospital and Clinic
Figure 16. Global Enzalutamide Soft Capsules Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Enzalutamide Soft Capsules Consumed in Retail Pharmacies
Figure 18. Global Enzalutamide Soft Capsules Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Enzalutamide Soft Capsules Consumed in Other
Figure 20. Global Enzalutamide Soft Capsules Market: Other (2021-2026) & (K Units)
Figure 21. Global Enzalutamide Soft Capsules Sale Market Share by Application (2025)
Figure 22. Global Enzalutamide Soft Capsules Revenue Market Share by Application in 2026
Figure 23. Enzalutamide Soft Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Enzalutamide Soft Capsules Sales Market Share by Company in 2026
Figure 25. Enzalutamide Soft Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Enzalutamide Soft Capsules Revenue Market Share by Company in 2026
Figure 27. Global Enzalutamide Soft Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Enzalutamide Soft Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Enzalutamide Soft Capsules Sales Market Share by Country in 2026
Figure 38. Americas Enzalutamide Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 40. Americas Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Enzalutamide Soft Capsules Sales Market Share by Region in 2026
Figure 46. APAC Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 48. APAC Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Enzalutamide Soft Capsules Sales Market Share by Country in 2026
Figure 57. Europe Enzalutamide Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 59. Europe Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Enzalutamide Soft Capsules in 2026
Figure 74. Manufacturing Process Analysis of Enzalutamide Soft Capsules
Figure 75. Industry Chain Structure of Enzalutamide Soft Capsules
Figure 76. Channels of Distribution
Figure 77. Global Enzalutamide Soft Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Enzalutamide Soft Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Enzalutamide Soft Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Enzalutamide Soft Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Enzalutamide Soft Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Enzalutamide Soft Capsules Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Enzalutamide Soft Capsules
Figure 2. Enzalutamide Soft Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzalutamide Soft Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Enzalutamide Soft Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Enzalutamide Soft Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Enzalutamide Soft Capsules Sales Market Share by Country/Region (2025)
Figure 10. Enzalutamide Soft Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Enzalutamide Soft Capsules Sales Market Share by Type in 2026
Figure 14. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Enzalutamide Soft Capsules Consumed in Hospital and Clinic
Figure 16. Global Enzalutamide Soft Capsules Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Enzalutamide Soft Capsules Consumed in Retail Pharmacies
Figure 18. Global Enzalutamide Soft Capsules Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Enzalutamide Soft Capsules Consumed in Other
Figure 20. Global Enzalutamide Soft Capsules Market: Other (2021-2026) & (K Units)
Figure 21. Global Enzalutamide Soft Capsules Sale Market Share by Application (2025)
Figure 22. Global Enzalutamide Soft Capsules Revenue Market Share by Application in 2026
Figure 23. Enzalutamide Soft Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Enzalutamide Soft Capsules Sales Market Share by Company in 2026
Figure 25. Enzalutamide Soft Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Enzalutamide Soft Capsules Revenue Market Share by Company in 2026
Figure 27. Global Enzalutamide Soft Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Enzalutamide Soft Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Enzalutamide Soft Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Enzalutamide Soft Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Enzalutamide Soft Capsules Sales Market Share by Country in 2026
Figure 38. Americas Enzalutamide Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 40. Americas Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Enzalutamide Soft Capsules Sales Market Share by Region in 2026
Figure 46. APAC Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 48. APAC Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Enzalutamide Soft Capsules Sales Market Share by Country in 2026
Figure 57. Europe Enzalutamide Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 59. Europe Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Enzalutamide Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Enzalutamide Soft Capsules in 2026
Figure 74. Manufacturing Process Analysis of Enzalutamide Soft Capsules
Figure 75. Industry Chain Structure of Enzalutamide Soft Capsules
Figure 76. Channels of Distribution
Figure 77. Global Enzalutamide Soft Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Enzalutamide Soft Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Enzalutamide Soft Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Enzalutamide Soft Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Enzalutamide Soft Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Enzalutamide Soft Capsules Revenue Market Share Forecast by Application (2027-2032)
